Quarterly Result13 Feb 2026, 05:05 pm
Caprolactam Chemicals Ltd Announces Q3 2025 Results with Revised Remunerations and Related Party Transactions
AI Summary
Caprolactam Chemicals Ltd has announced its unaudited standalone financial results for the quarter ended December 31, 2025. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on February 13, 2026. The company reported a (loss) before tax of INR 152.57 Crore. The Board also approved the revision in remuneration of the Chief Financial Officer cum Whole-Time Director and the Managing Director. Additionally, the Board approved related party transactions with Ms. Shital Bhanushali and a revision in consultancy fees payable by the company to a related party, Mr. Shankar Bhanushali.
Key Highlights
- Caprolactam Chemicals Ltd announced unaudited standalone financial results for Q3 2025.
- The results were reviewed by the Audit Committee and approved by the Board of Directors.
- The company reported a (loss) before tax of INR 152.57 Crore.
- The Board approved the revision in remuneration of the Chief Financial Officer cum Whole-Time Director and the Managing Director.
- The Board approved related party transactions with Ms. Shital Bhanushali and a revision in consultancy fees payable by the company to a related party, Mr. Shankar Bhanushali.
Price Impact
More from CAPRO